Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Cultural sensitivity, communication key to strengthening India's medical tourism appeal: IIM experts
Experts highlight cultural sensitivity and communication's importance for international medical tourists. Effective expectation management and communication enhance patient experiences in Indian hospitals. India is a leading medical tourism destination due to advanced healthcare and affordable costs. Hospitals should invest in intercultural communication training for professionals. Bridging cultural gaps improves patient satisfaction and India's market competitiveness.
Shilpa Medicare shares gain 5% after arm partners with Orion Corp for cancer treatment drug
Shilpa Medicare shares rose over 5% after its subsidiary partnered with Orion to co-develop and supply a nivolumab biosimilar for Europe. Orion will market the drug, while the Shilpa Medicare arm handles manufacturing. The deal aims to expand access to affordable cancer therapy.
Alembic Pharma gets USFDA nod for generic influenza treatment drug
Alembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. This development offers a more accessible option for patients aged two weeks and above suffering from acute, uncomplicated flu. The approval marks a significant step in providing affordable alternatives to the reference drug, Tamiflu, potentially impacting a market valued at an estimated USD 27 million.
India known as nation with world's largest healthcare programme: PM Modi
Prime Minister Narendra Modi said India has made healthcare more affordable and accessible over the past 12 years through initiatives such as Ayushman Bharat and the PM Bharatiya Jan Aushadhi Pariyojana. He highlighted lower-cost medicines and medical devices, expanded medical education, and progress in tackling diseases like tuberculosis.
India's healthcare transformed in 12 years under PM Modi: Report
India's healthcare sector has seen a major transformation over the last 12 years. Health insurance coverage has expanded significantly. Maternal and child healthcare has improved. Medical infrastructure has seen a substantial increase. The government has focused on making healthcare accessible and affordable for all citizens.
Alkem launches semaglutide in ready-to-use single-shot pre-filled syringes
Alkem is the first company in India to introduce semaglutide in single-shot pre-filled syringe format, expanding treatment options for patients and lowering entry barriers with its affordable pricing. The ready-to-use single shot pre-filled syringe format offers enhanced access, and convenience.
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss
Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordable for diabetes and obesity management. The company is the first in India to offer this convenient format. This move intensifies competition in the growing Indian drug market. Alkem aims to expand access to quality medicines for better patient care.
Govt health spending triples to Rs 3.85 lakh crore in 2022-23: National Health Accounts
Government spending on healthcare has surged to Rs 3.85 lakh crore in 2022-23, nearly tripling from a decade ago. This increased public investment has led to a substantial drop in household out-of-pocket expenses for treatment. The share of government health spending in GDP has also risen. This indicates a positive shift towards more affordable and accessible healthcare for all citizens.
Alembic gets USFDA nod for generic levothyroxine sodium tablets
Alembic Pharmaceuticals has secured final approval from the US health regulator for its generic levothyroxine sodium tablets. This medication is used as a replacement therapy for hypothyroidism. The approval covers multiple strengths of the tablets. This development is significant for patients seeking affordable treatment options. The market for these tablets is substantial.
Star Health and Allied Insurance rolls out 20% cheaper health cover for tier-2, tier-3 cities
Star Health and Allied Insurance is launching an affordable health insurance product for tier-2 and tier-3 cities, with premiums 20% lower than existing plans. This move aims to increase insurance penetration in smaller towns where affordability is a key barrier. The insurer is also developing a preferred hospital network called Pratham to enhance customer experience.
From oncology to obesity, Pfizer bets big on India for its next growth wave
Pfizer is focusing on India for future growth. The company plans to launch new medicines quickly and at affordable prices. India is seen as a crucial market for new treatments in cancer, obesity, and vaccines. Pfizer is also working on local clinical studies for future drug launches.
Star Health to launch affordable health insurance plans targeting tier 2, 3 markets
As healthcare expenses soar, Star Health is bracing for premium increases in the next fiscal year. In a proactive move, the insurer is rolling out a series of affordable health insurance options tailored for smaller urban areas. These plans will incorporate a curated list of hospitals to not only streamline costs but also enhance accessibility for policyholders in these communities.